According to the latest data from the Hong Kong Stock Exchange, on July 14th, Norges Bank reduced its holding in Pharmaron (HKEX: 03759) by 1.34 million shares. The transaction was executed at an average price of approximately HK$22.86 per share, resulting in a total consideration of around HK$30.53 million.

Following this disposal, the bank's latest shareholding stands at approximately 24.43 million shares, representing a stake of 6.93% in the company.